2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      TRIM28 facilitates type I interferon activation by targeting TBK1

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Type I interferons play a fundamental role in innate host defense against viral infections by eliciting the induction of an antiviral gene program that serves to inhibit viral replication. Activation of type I interferon is regulated by the IRF3 transcription factor, which undergoes phosphorylation-dependent activation by the upstream kinase, TBK1, during viral infection. However, the mechanisms by which TBK1 achieves activation to support signaling to IRF3 remain incompletely understood. Here we identified the E3 ubiquitin ligase, tripartite motif containing 28 (TRIM28), as a positive regulator of type I interferon activation by facilitating TBK1 signaling. Genetic deletion of TRIM28 via CRISPR-Cas9 editing resulted in impaired type I interferon activation upon both RNA and DNA virus challenge, corresponding with increased susceptibility to virus infections in TRIM28 knockout cells. Mechanistically, TRIM28 interacted with TBK1 and mediated the assembly of K63-linked ubiquitin chains onto TBK1, a post-translational modification shown to augment TBK1 signal transmission events. TRIM28 knockout cells further displayed defective TBK1 phosphorylation and complex assembly with IRF3, resulting in impaired IRF3 phosphorylation. Altogether, our data demonstrate TBK1 to be a novel substrate for TRIM28 and identify TRIM28 as an essential regulatory factor in controlling innate antiviral immune responses.

          Related collections

          Most cited references53

          • Record: found
          • Abstract: found
          • Article: not found

          TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity.

          Retinoic-acid-inducible gene-I (RIG-I; also called DDX58) is a cytosolic viral RNA receptor that interacts with MAVS (also called VISA, IPS-1 or Cardif) to induce type I interferon-mediated host protective innate immunity against viral infection. Furthermore, members of the tripartite motif (TRIM) protein family, which contain a cluster of a RING-finger domain, a B box/coiled-coil domain and a SPRY domain, are involved in various cellular processes, including cell proliferation and antiviral activity. Here we report that the amino-terminal caspase recruitment domains (CARDs) of RIG-I undergo robust ubiquitination induced by TRIM25 in mammalian cells. The carboxy-terminal SPRY domain of TRIM25 interacts with the N-terminal CARDs of RIG-I; this interaction effectively delivers the Lys 63-linked ubiquitin moiety to the N-terminal CARDs of RIG-I, resulting in a marked increase in RIG-I downstream signalling activity. The Lys 172 residue of RIG-I is critical for efficient TRIM25-mediated ubiquitination and for MAVS binding, as well as the ability of RIG-I to induce antiviral signal transduction. Furthermore, gene targeting demonstrates that TRIM25 is essential not only for RIG-I ubiquitination but also for RIG-I-mediated interferon- production and antiviral activity in response to RNA virus infection. Thus, we demonstrate that TRIM25 E3 ubiquitin ligase induces the Lys 63-linked ubiquitination of RIG-I, which is crucial for the cytosolic RIG-I signalling pathway to elicit host antiviral innate immunity.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            KAP1 controls endogenous retroviruses in embryonic stem cells.

            More than forty per cent of the mammalian genome is derived from retroelements, of which about one-quarter are endogenous retroviruses (ERVs). Some are still active, notably in mice the highly polymorphic early transposon (ETn)/MusD and intracisternal A-type particles (IAP). ERVs are transcriptionally silenced during early embryogenesis by histone and DNA methylation (and reviewed in ref. 7), although the initiators of this process, which is essential to protect genome integrity, remain largely unknown. KAP1 (KRAB-associated protein 1, also known as tripartite motif-containing protein 28, TRIM28) represses genes by recruiting the histone methyltransferase SETDB1, heterochromatin protein 1 (HP1) and the NuRD histone deacetylase complex, but few of its physiological targets are known. Two lines of evidence suggest that KAP1-mediated repression could contribute to the control of ERVs: first, KAP1 can trigger permanent gene silencing during early embryogenesis, and second, a KAP1 complex silences the retrovirus murine leukaemia virus in embryonic cells. Consistent with this hypothesis, here we show that KAP1 deletion leads to a marked upregulation of a range of ERVs, in particular IAP elements, in mouse embryonic stem (ES) cells and in early embryos. We further demonstrate that KAP1 acts synergistically with DNA methylation to silence IAP elements, and that it is enriched at the 5' untranslated region (5'UTR) of IAP genomes, where KAP1 deletion leads to the loss of histone 3 lysine 9 trimethylation (H3K9me3), a hallmark of KAP1-mediated repression. Correspondingly, IAP 5'UTR sequences can impose in cis KAP1-dependent repression on a heterologous promoter in ES cells. Our results establish that KAP1 controls endogenous retroelements during early embryonic development.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Detection of Microbial Infections Through Innate Immune Sensing of Nucleic Acids

                Bookmark

                Author and article information

                Contributors
                Role: Role: Role: Role: Role: Role:
                Role: Role:
                URI : https://loop.frontiersin.org/people/983371Role: Role: Role: Role:
                Journal
                Front Immunol
                Front Immunol
                Front. Immunol.
                Frontiers in Immunology
                Frontiers Media S.A.
                1664-3224
                01 March 2024
                2024
                : 15
                : 1279920
                Affiliations
                [1] Department of Microbiology and Immunology, Tulane University School of Medicine , New Orleans, LA, United States
                Author notes

                Edited by: Junji Xing, Houston Methodist Research Institute, United States

                Reviewed by: Ran Cheng, Baylor College of Medicine, United States

                Michiel Van Gent, Erasmus Medical Center, Netherlands

                *Correspondence: Kislay Parvatiyar, kparvatiyar@ 123456tulane.edu
                Article
                10.3389/fimmu.2024.1279920
                10940511
                38495890
                85807815-d198-4164-8a57-db221ea9a64a
                Copyright © 2024 Hua, Nass and Parvatiyar

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 18 August 2023
                : 19 January 2024
                Page count
                Figures: 9, Tables: 0, Equations: 0, References: 53, Pages: 13, Words: 5329
                Funding
                Funded by: Louisiana Board of Regents , doi 10.13039/100006952;
                Funded by: National Institutes of Health , doi 10.13039/100000002;
                The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by the Louisiana Board of Regents (LEQSF (2021-24)-RD-A-33), the COBRE in aging and regenerative medicine (P30GM145498), and the National Institutes of Health R21AI178469 (awarded to KP).
                Categories
                Immunology
                Original Research
                Custom metadata
                Molecular Innate Immunity

                Immunology
                trim28,tripartite motif containing 28,tbk1,type i interferon (ifn),pattern recognition receptor (prr)

                Comments

                Comment on this article